Invention Grant
![Pyrazolo[1,5-A]pyrazin-4-yl and related derivatives](/docs/US/2022-02-22/US11254668B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrazolo[1,5-A]pyrazin-4-yl and related derivatives
-
Application No.: US16638271Application Date: 2018-08-09
-
Publication No.: US11254668B2Publication Date: 2022-02-22
- Inventor: Brian Stephen Gerstenberger , Andrew Fensome , Dafydd Rhys Owen , Matthew Frank Brown , Matthew Merrill Hayward , Felix Vajdos , Li Huang Xing , Stephen Wayne Wright
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent A. David Jordan
- International Application: PCT/IB2018/056007 WO 20180809
- International Announcement: WO2019/034973 WO 20190221
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D401/04 ; C07D401/14 ; C07D405/14 ; C07D519/00
![Pyrazolo[1,5-A]pyrazin-4-yl and related derivatives](/abs-image/US/2022/02/22/US11254668B2/abs.jpg.150x150.jpg)
Abstract:
A compound having the structure: or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of said compound or pharmaceutically acceptable salt, wherein variables are defined in the specification. Also provided are methods of treatment as Janus Kinase inhibitors and pharmaceutical compositions containing the compounds of the invention and combinations thereof with other therapeutic agents.
Public/Granted literature
- US20200172537A1 PYRAZOLO[1,5-A]PYRAZIN-4-YL AND RELATED DERIVATIVES Public/Granted day:2020-06-04
Information query
